{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T07:19:10Z","timestamp":1777101550388,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016015","name":"University Hospital of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016015","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Abviris Deutschland GmbH"},{"DOI":"10.13039\/501100013362","name":"Swiss Cancer Research Foundation","doi-asserted-by":"publisher","award":["BIL KFS-4986-02-2020"],"award-info":[{"award-number":["BIL KFS-4986-02-2020"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009736","name":"Freiwillige Akademische Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cervical cancer (CC) is nearly always caused by persistent human papillomavirus (HPV) infection. It is the most common cancer among women living with HIV (WLWH) and is the leading cause of cancer-related death in women in East Africa, with 10,241 new cases reported in Tanzania in 2020. In 2019, the World Health Organization (WHO) presented a global strategy for the elimination of CC as a public health problem, proposing targets to meet by 2030 for HPV vaccine coverage (90% of all 15-year-old girls), CC screening (70% of all women once at 35 and again at 45\u00a0years of age) and treatment delivery, to be scaled at national and subnational levels with a context-sensitive approach. This study aims to evaluate the upscaling of screening and treatment services at a rural referral hospital in Tanzania in order to address the second and third WHO targets.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is an implementation study with a before-and-after design performed at St. Francis Referral Hospital (SFRH) in Ifakara (south-central Tanzania). CC screening and treatment services are integrated within the local HIV Care and Treatment Center (CTC). The standard of care, consisting of visualization of the cervix with acetic acid (VIA) and cryotherapy has been up-scaled with self-sampled HPV testing and also involved the introduction of mobile colposcopy, thermal ablation and loop electrosurgical excision procedure (LEEP). Participants are WLWH aged 18 to 65\u00a0years. Outcome measures included the percentage of women screened, HPV prevalence and genotype, and adherence to screening, treatment and follow-up plan. Additionally, we will explore the performance of novel diagnostic tests (QG-MPH\u00ae, Prevo-Check\u00ae and PT Monitor\u00ae), which share the features of being manageable and inexpensive, and thus a potential tool for effective triage in HPV high-prevalence cohorts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>The study will provide relevant information about HPV prevalence and persistence, as well as reproductive and lifestyle indicators in a CC high-risk cohort of WLWH and about upscaling screening and treatment services at the level of a rural referral hospital in Tanzania. Furthermore, it will provide exploratory data on novel assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov Identifier: NCT05256862, date of registration 25\/02\/2022. Retrospectively registered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-023-09113-3","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T02:02:53Z","timestamp":1678413773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Upscaling cervical cancer screening and treatment for women living with HIV at a rural referral hospital in Tanzania: protocol of a before-and-after study exploring HPV testing and novel diagnostics"],"prefix":"10.1186","volume":"23","author":[{"given":"Ivana","family":"Di Salvo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorcas","family":"Mnzava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Jacopo","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Senkoro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Ndege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy J.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalia Tobias","family":"Makunja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George I.","family":"Kassiga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas M.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Weisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9 B.","family":"Kind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"issue":"1","key":"9113_CR1","first-page":"73","volume":"68","author":"S Wardak","year":"2016","unstructured":"Wardak S. Human Papillomavirus (HPV) and cervical cancer. Med Dosw Mikrobiol. 2016;68(1):73\u201384.","journal-title":"Med Dosw Mikrobiol"},{"issue":"6","key":"9113_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"9113_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/QAD.0000000000001765","volume":"32","author":"G Liu","year":"2018","unstructured":"Liu G, Sharma M, Tan N, Barnabas RV. HIV-positive women have higher risk of human papilloma virus infection, precancerous lesions, and cervical cancer. AIDS. 2018;32(6):795\u2013808.","journal-title":"AIDS"},{"issue":"6","key":"9113_CR4","doi-asserted-by":"publisher","first-page":"e25110","DOI":"10.1002\/jia2.25110","volume":"21","author":"KJ Looker","year":"2018","unstructured":"Looker KJ, R\u00f6nn MM, Brock PM, Brisson M, Drolet M, Mayaud P, et al. Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status. J Int AIDS Soc. 2018;21(6):e25110.","journal-title":"J Int AIDS Soc"},{"issue":"10071","key":"9113_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S0140-6736(16)31392-7","volume":"389","author":"O Ginsburg","year":"2017","unstructured":"Ginsburg O, Bray F, Coleman MP, Vanderpuye V, Eniu A, Kotha SR, et al. The global burden of women\u2019s cancers: a grand challenge in global health. Lancet. 2017;389(10071):847\u201360.","journal-title":"Lancet"},{"issue":"1","key":"9113_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-017-0670-9","volume":"7","author":"W Mapanga","year":"2018","unstructured":"Mapanga W, Girdler-Brown B, Feresu SA, Chipato T, Singh E. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review. Syst Rev. 2018;7(1):1\u201327.","journal-title":"Syst Rev"},{"issue":"7188","key":"9113_CR7","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1136\/bmj.318.7188.904","volume":"318","author":"M Quinn","year":"1999","unstructured":"Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999;318(7188):904.","journal-title":"BMJ"},{"key":"9113_CR8","volume-title":"Cervical cancer","author":"WHO","year":"2022","unstructured":"WHO. Cervical cancer. 2022. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cervical-cancer. Cited 2022 Apr 20.\u00a0"},{"issue":"4","key":"9113_CR9","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/QAI.0b013e31828177d7","volume":"62","author":"AG Abraham","year":"2013","unstructured":"Abraham AG, D\u2019Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, et al. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr. 2013;62(4):405\u201313.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"9113_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/IJWH.S153003","volume":"16","author":"DY Mohammed","year":"2018","unstructured":"Mohammed DY, Shukla P, Babayants Y, Sison R, Slim J. Increased proportions of HIV-infected women met cervical cancer screening guideline in 2016. Int J Womens Health. 2018;16(10):83\u20137.","journal-title":"Int J Womens Health"},{"key":"9113_CR11","volume-title":"Global strategy to accelerate the elimination of cervical cancer as a public health problem","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem. 2020."},{"key":"9113_CR12","unstructured":"IARC\/WHO. Tanzania, United Republic of 2020. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/834-tanzania-united-republic-of-fact-sheets.pdf."},{"issue":"1","key":"9113_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1200\/JGO.2015.002964","volume":"3","author":"RS Chambuso","year":"2016","unstructured":"Chambuso RS, Shadrack S, Lidenge SJ, Mwakibete N, Medeiros RM. Influence of HIV\/AIDS on cervical cancer: a retrospective study from Tanzania. J Glob Oncol. 2016;3(1):72\u20138.","journal-title":"J Glob Oncol"},{"issue":"9","key":"9113_CR14","doi-asserted-by":"publisher","first-page":"e038531","DOI":"10.1136\/bmjopen-2020-038531","volume":"10","author":"B McHome","year":"2020","unstructured":"McHome B, Swai P, Wu C, Katanga J, Kahesa C, Manongi R, et al. Comprehensive Cervical Cancer Prevention in Tanzania (CONCEPT) study: Cohort profile. BMJ Open. 2020;10(9):e038531.","journal-title":"BMJ Open"},{"key":"9113_CR15","first-page":"29","volume":"1","author":"AS Runge","year":"2019","unstructured":"Runge AS, Bernstein ME, Lucas AN, Tewari KS. Cervical cancer in Tanzania: a systematic review of current challenges in six domains. Gynecol Oncol Rep. 2019;1:29.","journal-title":"Gynecol Oncol Rep"},{"key":"9113_CR16","doi-asserted-by":"publisher","first-page":"A2","DOI":"10.1016\/j.vaccine.2021.04.025","volume":"40","author":"A Mphuru","year":"2022","unstructured":"Mphuru A, Li AJ, Kyesi F, Mwengee W, Mazige F, Nshunju R, et al. National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation. Vaccine. 2022;40:A2-9.","journal-title":"Vaccine"},{"issue":"2","key":"9113_CR17","doi-asserted-by":"publisher","first-page":"e024011","DOI":"10.1136\/bmjopen-2018-024011","volume":"9","author":"DS Linde","year":"2019","unstructured":"Linde DS, Rasch V, Mwaiselage JD, Gammeltoft TM. Competing needs: a qualitative study of cervical cancer screening attendance among HPV-positive women in Tanzania. BMJ Open. 2019;9(2):e024011.","journal-title":"BMJ Open"},{"key":"9113_CR18","volume-title":"WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer","author":"WHO","year":"2018","unstructured":"WHO. WHO Director-General calls for all countries to take action to help end the suffering caused by cervical cancer. 2018.\u00a0Available from:\u00a0https:\/\/www.who.int\/news\/item\/18-05-2018-who-dg-calls-for-all-countries-to-take-action-to-help-end-the-suffering-caused-by-cervical-cancer. Cited 2022 Apr 20.\u00a0"},{"issue":"5","key":"9113_CR19","doi-asserted-by":"publisher","first-page":"e0231388","DOI":"10.1371\/journal.pone.0231388","volume":"15","author":"MT Hall","year":"2020","unstructured":"Hall MT, Smith MA, Simms KT, Barnabas RV, Canfell K, Murray JM. The past, present and future impact of HIV prevention and control on HPV and cervical disease in Tanzania: a modelling study. PLoS ONE. 2020;15(5):e0231388.","journal-title":"PLoS ONE"},{"issue":"3","key":"9113_CR20","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1136\/bmjgh-2019-001886","volume":"5","author":"PN Perez-Guzman","year":"2020","unstructured":"Perez-Guzman PN, Chung MH, De Vuyst H, Dalal S, Mutai KK, Muthoni K, et al. The impact of scaling up cervical cancer screening and treatment services among women living with HIV in Kenya: a modelling study. BMJ Glob Health. 2020;5(3):1886.","journal-title":"BMJ Glob Health"},{"key":"9113_CR21","doi-asserted-by":"publisher","first-page":"106900","DOI":"10.1016\/j.ypmed.2021.106900","volume":"154","author":"B Serrano","year":"2022","unstructured":"Serrano B, Ib\u00e1\u00f1ez R, Robles C, Peremiquel-Trillas P, de Sanjos\u00e9 S, Bruni L. Worldwide use of HPV self-sampling for cervical cancer screening. Prev Med (Baltim). 2022;154:106900.","journal-title":"Prev Med (Baltim)"},{"issue":"10","key":"9113_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1158\/1940-6207.CAPR-19-0192","volume":"12","author":"T Agorastos","year":"2019","unstructured":"Agorastos T, Chatzistamatiou K, Tsertanidou A, Mouchtaropoulou E, Pasentsis K, Kitsou A, et al. Implementation of HPV-based cervical cancer screening combined with self-sampling using a midwifery network Across Rural Greece: the Grecoself study. Cancer Prev Res. 2019;12(10):701\u201310.","journal-title":"Cancer Prev Res"},{"issue":"7","key":"9113_CR23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1158\/1940-6207.CAPR-19-0485","volume":"13","author":"M Gizaw","year":"2020","unstructured":"Gizaw M, Teka B, Ruddies F, Kassahun K, Worku D, Worku A, et al. Reasons for not attending cervical cancer screening and associated factors in Rural Ethiopia. Cancer Prev Res (Phila). 2020;13(7):593\u20139.","journal-title":"Cancer Prev Res (Phila)"},{"issue":"3","key":"9113_CR24","doi-asserted-by":"publisher","first-page":"e035153","DOI":"10.1136\/bmjopen-2019-035153","volume":"10","author":"A Goldstein","year":"2020","unstructured":"Goldstein A, Goldstein LS, Lipson R, Bedell S, Wang J, Stamper SA, et al. Assessing the feasibility of a rapid, high-volume cervical cancer screening programme using HPV self-sampling and digital colposcopy in rural regions of Yunnan, China. BMJ Open. 2020;10(3):e035153.","journal-title":"BMJ Open"},{"key":"9113_CR25","first-page":"132","volume":"1","author":"C Malone","year":"2020","unstructured":"Malone C, Barnabas RV, Buist DSM, Tiro JA, Winer RL. Cost-effectiveness studies of HPV self-sampling: a systematic review. Prev Med (Baltim). 2020;1:132.","journal-title":"Prev Med (Baltim)"},{"issue":"1","key":"9113_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-020-00917-7","volume":"20","author":"A Bakiewicz","year":"2020","unstructured":"Bakiewicz A, Rasch V, Mwaiselage J, Linde DS. \u201cthe best thing is that you are doing it for yourself\u201d - Perspectives on acceptability and feasibility of HPV self-sampling among cervical cancer screening clients in Tanzania: a qualitative pilot study. BMC Womens Health. 2020;20(1):1\u20139.","journal-title":"BMC Womens Health"},{"issue":"9","key":"9113_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2147\/IJWH.S103868","volume":"2","author":"M Viviano","year":"2017","unstructured":"Viviano M, De Beaudrap P, Tebeu PM, Fouogue JT, Vassilakos P, Petignat P. A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa. Int J Womens Health. 2017;2(9):69.","journal-title":"Int J Womens Health"},{"key":"9113_CR28","doi-asserted-by":"publisher","unstructured":"Letang E, Kalinjuma AV, Glass TR, Gamell A, Mapesi H, Sikalengo GR, Luwanda LB, Mnzava D, Ntamatungiro AJ, Ndaki R, Francis G, Vanobberghen F, Furrer H, Klimkait T, Felger I, Tanner M, Hatz C, Weisser M, Battegay M, Kiularco Study Group. Cohort profile: The Kilombero and Ulanga Antiretroviral Cohort (KIULARCO) - A prospective HIV cohort in rural Tanzania. Swiss Med Wkly. 2017;147:w14485. https:\/\/doi.org\/10.4414\/smw.2017.14485.","DOI":"10.4414\/smw.2017.14485"},{"issue":"56","key":"9113_CR29","doi-asserted-by":"publisher","first-page":"102804","DOI":"10.1016\/j.ebiom.2020.102804","volume":"1","author":"T Weiland","year":"2020","unstructured":"Weiland T, Eckert A, Tomazic PV, Wolf A, Pondorfer P, Vasicek S, et al. DRH1 \u2013 a novel blood-based HPV tumour marker. EBioMedicine. 2020;1(56):102804.","journal-title":"EBioMedicine"},{"key":"9113_CR30","volume-title":"The Chronic Diseases Clinic of Ifakara (CDCI) and the Kilombero and Ulanga Antiretroviral Cohort Study (KIULARCO) at the St. Francis Referral Hospital Annual Report 2020","author":"DM Weisser","year":"2020","unstructured":"Weisser DM, Mapesi H, Gingo W, Masanja F, Battegay M, Furrer H, Gamell A, Hatz CFR, Katende A, Letang E, Luoga E, Lwanda LB, Mollel GJ, Mbwanij G, Ndege RC, Ntamatungiro AJ, Rohacek M, Samson L, Moshi LT. The Chronic Diseases Clinic of Ifakara (CDCI) and the Kilombero and Ulanga Antiretroviral Cohort Study (KIULARCO) at the St. Francis Referral Hospital Annual Report 2020. 2020."},{"key":"9113_CR31","volume-title":"Evalyn\u00ae brush","author":"Rovers Medical Devices","year":"2022","unstructured":"Rovers Medical Devices. Evalyn\u00ae brush. 2022."},{"issue":"2","key":"9113_CR32","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S1470-2045(18)30763-0","volume":"20","author":"NJ Polman","year":"2019","unstructured":"Polman NJ, Ebisch RMF, Heideman DAM, Melchers WJG, Bekkers RLM, Molijn AC, et al. Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial. Lancet Oncol. 2019;20(2):229\u201338.","journal-title":"Lancet Oncol"},{"key":"9113_CR33","unstructured":"Basu P, Rengaswamy Sankaranarayanan EL. Colposcopy Digital Atlas. 2022. Available from: https:\/\/screening.iarc.fr\/atlascolpo.php. Cited 2022 Apr 20."},{"key":"9113_CR34","volume-title":"A method for determining the severity or grade of Human Papillomavirus (Hpv)-induced dysplasia","author":"A Kaufmann","year":"2020","unstructured":"Kaufmann A. A method for determining the severity or grade of Human Papillomavirus (Hpv)-induced dysplasia. 2020.\u00a0Available from:\u00a0https:\/\/patentscope.wipo.int\/search\/en\/detail.jsf?docId=WO2020161285. Cited 2022 Apr 20.\u00a0"},{"key":"9113_CR35","doi-asserted-by":"publisher","unstructured":"Martin-Hirsch PP, Paraskevaidis E, Bryant A, Dickinson HO, Keep SL. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev. 2010;(6):CD001318. https:\/\/doi.org\/10.1002\/14651858.CD001318.pub2. Update in: Cochrane Database Syst Rev. 2013;12:CD001318. PMID: 20556751; PMCID: PMC4170911.","DOI":"10.1002\/14651858.CD001318.pub2"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09113-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-09113-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09113-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T02:04:05Z","timestamp":1678413845000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-09113-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["9113"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-09113-3","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"28 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This protocol was approved by the Institutional Review Board of the Ifakara Health Institute IHI-IRB (IHI\/IRB\/No: 43\u20132020), National Institute for Medical Research in Tanzania (NIMR\/HQ\/R.8a\/ Vol. IX\/3611) and the Tanzania Medicines and Medical Devices Authority (TMDA-WEB0021\/CTR\/002\/03) in Tanzania; and Ethikkommission Nordwest- und Zentralschweiz (AO_2021_00006) in Switzerland.Informed consent from study participants is written.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no competing interests. AKa declares he is inventor of QG-MPH and will receive royalties if the assay will be commercially implemented, which at this point is not the case.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"234"}}